Your session is about to expire
← Back to Search
Passive and Functional Electric Stimulation Cycling for Spinal Cord Injury
N/A
Waitlist Available
Led By Ann S Choe, Ph.D.
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline fmri brain parcels at 2 weeks and 4 weeks after the start of intervention.
Summary
This trial will use a type of MRI that does not require performance of explicit motor tasks to detect early changes in the brain during intervention in spinal cord injury patients. The changes will be predictive of recovery.
Eligible Conditions
- Spinal Cord Injury
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline isncsci scores at 2 weeks and 4 weeks after the start of intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline isncsci scores at 2 weeks and 4 weeks after the start of intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Spinal Cord Injuries
Resting state fMRI brain parcels
Resting state fMRI functional connectivity
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Functional Electric Stimulation cyclingActive Control1 Intervention
The Functional Electrical Stimulation (FES) cycling group will use RT300 ergometer (Restorative Therapies, Inc) with stimulation on.
Group II: Passive CyclingPlacebo Group1 Intervention
The passive cycling group will use the same RT300 ergometer with stimulation off.
Find a Location
Who is running the clinical trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
88 Previous Clinical Trials
24,829 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,368 Previous Clinical Trials
652,241 Total Patients Enrolled
Ann S Choe, Ph.D.Principal InvestigatorJohns Hopkins University
Share this study with friends
Copy Link
Messenger